ストックスクリーナーアプリを入手
17.58
8.20%
-1.57
アフターアワーズ：
17.69
0.11
+0.63%
Immunome Inc (IMNM) 最新ニュース
Price-Driven Insight from (IMNM) for Rule-Based Strategy - Stock Traders Daily
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Immunome stock holds at Stifel as Bristol deal cleans up license - Investing.com
ImmunomeEnters Amendment No. 4 To License Agreement With Bristol-Myers Squibb Company On Oct 2, 2026 - TradingView
Immunome stock gets FDA clearance for fifth clinical program - AD HOC NEWS
Immunome, Inc. (IMNM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Immunome (IMNM) Is Down 6.5% After FDA Clears IND For Novel ADC IM-1340 Trial – Has The Bull Case Changed? - Yahoo Finance
IMNM Initiated Coverage by Stifel -- Rated Hold with PT at $24.0 - gurufocus.com
Stifel Initiates Immunome at Hold With $24 Price Target - Yahoo Finance
Immunome (IMNM) Stock Looks Near Fair Value As Its 186% Run Continues - Yahoo Finance
Immunome gains FDA IND clearance for IM‑1340 solid tumour study - Mugglehead Investment Magazine
Stifel initiates Immunome stock coverage with Hold rating at $24 By Investing.com - Investing.com Nigeria
Stifel initiates Immunome stock coverage with Hold rating at $24 - Investing.com
Stifel initiates Immunome stock coverage with Hold rating at $24 By Investing.com - Investing.com South Africa
Immunome (IMNM) Gains FDA IND Clearance for IM-1340 Targeting Ad - gurufocus.com
Immunome receives FDA clearance for IM-1340 solid tumor trial - Investing.com
Immunome receives FDA clearance for IM-1340 solid tumor trial By Investing.com - Investing.com South Africa
Immunome Announces IND Clearance for IM-1340, a Potential First-in-Class Antibody-Drug Conjugate for the Treatment of Solid Tumors - Business Wire
(IMNM) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
A. G. P. Initiates Immunome(IMNM.US) With Buy Rating, Announces Target Price $32 - Moomoo
IMNM Initiates Coverage On Alliance Global Partners -- Rating Se - GuruFocus
Immunome (Nasdaq:IMNM)Stock Analysis - Simply Wall Street
Immunome Stock Price Forecast. Should You Buy IMNM? - StockInvest.us
Immunome, Inc. (IMNM) Stock Analysis: Exploring a 51.72% Potential Upside in Biotechnology - DirectorsTalk Interviews
Immunome CSO Higgins Jack Executes 18,000 Options at $1.35, Sells and Gifts Shares (NASDAQ: IMNM) - Kalkine Media
Immunome Inc. (IMNM) Edges Up 2.51% to $24.55 as Buyers Hold Above Key SupportPCR Spike - careplusvn.com
Liquidity Mapping Around (IMNM) Price Events - Stock Traders Daily
Planned sale of 13,200 Immunome (NASDAQ: IMNM) shares disclosed in Rule 144 notice - Stock Titan
IMNM Reiterated by HC Wainwright & Co. -- Price Target Maintained at $40 - GuruFocus
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
GOOG: Alphabet IncOrdinary SharesClass C Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Immunome, Inc. Revenue Breakdown – NASDAQ:IMNM - TradingView
Immunome to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
Immunome (NASDAQ:IMNM) Is In A Good Position To Deliver On Growth Plans - Moomoo
(IMNM) Volatility Zones as Tactical Triggers - Stock Traders Daily
Immunome (IMNM) Reports A Wider Loss, Is The Premium Valuation Justified? - Sahm
Immunome (IMNM) Update: Closes 0.98% Lower at $28.24 at the Close; Chart Watch: Traders Can Monitor the $26.83-$29.65 Range in the Current UpdateCommon Gap - siam.in
Immunome (IMNM) Update: Closes 0.98% Lower at $28.24 at the Close; Chart Watch: Traders Can Monitor the $26.83-$29.65 Range in the Current UpdateSmart Beta Flow - vinanet.vn
Immunome (IMNM) Results Review: EPS Clears the Reported Estimate for the Current Session; Closing Move - dars.gov.et
Should Immunome’s (IMNM) Rising Losses and ESOP Shelf Offering Require Action From Investors? - Sahm
Should Immunome’s (IMNM) Rising Losses and ESOP Shelf Offering Require Action From Investors? - simplywall.st
Enterprise value to revenue forward of Immunome, Inc. – NASDAQ:IMNM - TradingView
Bank of America Corp DE Boosts Stake in Immunome, Inc. $IMNM - MarketBeat
Enterprise value to EBIT forward of Immunome, Inc. – NASDAQ:IMNM - TradingView
Immunome (NASDAQ:IMNM) Sets New 12-Month HighShould You Buy? - MarketBeat
Immunome (IMNM) Faces A Valuation Test Following Earnings And Shelf Registration - Sahm
Immunome, Inc. (NASDAQ:IMNM) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
IMNM Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Cost Discipline at Pre-Revenue Oncology BiotechBuyback Announcement Report - vinanet.vn
Is Immunome’s (IMNM) Russell Exit Quietly Recasting Its Shareholder Base And Liquidity Story? - Sahm
Immunome director Isaac Barchas sells $940,453 in common stock - Investing.com
0.44%
1.26%
大文字化:
|
ボリューム (24 時間):